Detalhe da pesquisa
1.
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.
Circulation
; 140(3): 240-261, 2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116032
2.
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
Eur Heart J
; 40(31): 2632-2653, 2019 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116395
3.
Outcomes following implantation of the Biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry.
Catheter Cardiovasc Interv
; 86(7): 1151-60, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683225
4.
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial.
Lancet
; 378(9807): 1940-8, 2011 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075451
5.
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.
Eur Heart J
; 31(2): 165-76, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19889649
6.
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.
J Am Coll Cardiol
; 76(12): 1468-1483, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943165
7.
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.
Lancet
; 372(9644): 1163-73, 2008 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-18765162
8.
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.
EuroIntervention
; 14(4): e418-e425, 2018 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29790477
9.
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.
Cardiol J
; 23(6): 626-636, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27665852
10.
Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction.
Heart
; 101(4): 271-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25423953
11.
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
JACC Cardiovasc Interv
; 6(8): 777-89, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23968698
12.
The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.
EuroIntervention
; 6(8): 928-35, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21330239
13.
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.
EuroIntervention
; 6(2): 233-9, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20562074
14.
The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).
Am J Cardiol
; 105(4): 475-9, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20152241